"It would be so much easier": health system-led genetic risk notification-feasibility and acceptability of cascade screening in an integrated system
- PMID: 30843145
- PMCID: PMC6754469
- DOI: 10.1007/s12687-019-00412-z
"It would be so much easier": health system-led genetic risk notification-feasibility and acceptability of cascade screening in an integrated system
Abstract
Assess the feasibility and acceptability of health system-led genetic risk notification in a US integrated health system. We conducted semi-structured phone interviews with individuals age 40-64 years who had undergone genetic sequencing, but had not yet received their results, assessing attitudes to direct outreach to relatives. During each interview, we collected contact information for adult relatives identified as members of the same system and attempted to identify each relative in administrative data. We conducted 20 interviews. Most participants expressed support for Kaiser Permanente Washington involvement in familial risk notification. Direct outreach to relatives received the most unqualified support; outreach to the relatives' physician or interaction with the relatives' electronic medical record received more tempered support. Support was motivated by the desire to have risk communicated accurately and quickly. The most common caveat was a desire to alert relatives before the health system contacted them. Of 57 named relatives who were members of the same health system, we retrieved a single match for 40 (70.2%) based on name or birthdate. Health system involvement in familial risk notification received support in a sample of patients in a US integrated health system, and identification of relatives is feasible.
Keywords: Bioethics; Cascade testing; Communication; Genetic testing; Risk notification.
Conflict of interest statement
The authors declare that they have no competing interests.
Similar articles
-
Feasibility, acceptability, and limited efficacy of health system-led familial risk notification: protocol for a mixed-methods evaluation.Pilot Feasibility Stud. 2022 Aug 9;8(1):174. doi: 10.1186/s40814-022-01142-9. Pilot Feasibility Stud. 2022. PMID: 35945632 Free PMC article.
-
Alternative cascade-testing protocols for identifying and managing patients with familial hypercholesterolaemia: systematic reviews, qualitative study and cost-effectiveness analysis.Health Technol Assess. 2023 Oct;27(16):1-140. doi: 10.3310/CTMD0148. Health Technol Assess. 2023. PMID: 37924278 Free PMC article.
-
Extended Family Outreach in Hereditary Cancer Using Web-Based Genealogy, Direct-to-Consumer Ancestry Genetics, and Social Media: Mixed Methods Process Evaluation of the ConnectMyVariant Intervention.JMIR Cancer. 2023 Apr 20;9:e43126. doi: 10.2196/43126. JMIR Cancer. 2023. PMID: 37079361 Free PMC article.
-
Modern Family: An Ethical Justification for System-Led Contact of Relatives Eligible for Cascade Screening in the United States.Public Health Genomics. 2025;28(1):19-33. doi: 10.1159/000541301. Epub 2024 Nov 9. Public Health Genomics. 2025. PMID: 39522512 Review.
-
Communicating risk with relatives in a familial hypercholesterolemia cascade screening program: a summary of the evidence.J Cardiovasc Nurs. 2015 Jul-Aug;30(4):E1-E12. doi: 10.1097/JCN.0000000000000153. J Cardiovasc Nurs. 2015. PMID: 24831729 Review.
Cited by
-
Environmental scan of family chart linking for genetic cascade screening in a U.S. integrated health system.Front Genet. 2022 Aug 11;13:886650. doi: 10.3389/fgene.2022.886650. eCollection 2022. Front Genet. 2022. PMID: 36035175 Free PMC article.
-
Patients' perceptions and practices of informing relatives: a qualitative study within a randomised trial on healthcare-assisted risk disclosure.Eur J Hum Genet. 2024 Apr;32(4):448-455. doi: 10.1038/s41431-024-01544-8. Epub 2024 Feb 2. Eur J Hum Genet. 2024. PMID: 38308085 Free PMC article. Clinical Trial.
-
Health professionals contacting patients' relatives directly about genetic risk (with patient consent): current clinical practice and perspectives.Eur J Hum Genet. 2025 Apr;33(4):476-484. doi: 10.1038/s41431-024-01730-8. Epub 2024 Dec 19. Eur J Hum Genet. 2025. PMID: 39702589
-
Health System-Led Early Consent and Direct Contact of At-Risk Relatives: Pilot Study Results.Public Health Genomics. 2025;28(1):150-162. doi: 10.1159/000545404. Epub 2025 Apr 3. Public Health Genomics. 2025. PMID: 40179849
-
An Examination of the Ethical and Legal Limits in Implementing "Traceback Testing" for Deceased Patients.J Law Med Ethics. 2022;50(4):818-832. doi: 10.1017/jme.2023.23. J Law Med Ethics. 2022. PMID: 36883408 Free PMC article.
References
-
- Aktan-Collan K, Haukkala A, Pylvanainen K, Jarvinen HJ, Aaltonen LA, Peltomaki P, Rantanen E, Kaariainen H, Mecklin JP. Direct contact in inviting high-risk members of hereditary colon cancer families to genetic counselling and DNA testing. J Med Genet. 2007;44:732–738. doi: 10.1136/jmg.2007.051581. - DOI - PMC - PubMed
-
- Benkendorf JL, Reutenauer JE, Hughes CA, Eads N, Willison J, Powers M, Lerman C. Patients' attitudes about autonomy and confidentiality in genetic testing for breast-ovarian cancer susceptibility. Am J Med Genet. 1997;73:296–303. doi: 10.1002/(SICI)1096-8628(19971219)73:3<296::AID-AJMG13>3.0.CO;2-E. - DOI - PubMed
-
- Clayton EW. Genetics, public health, and the law. In: Khoury MJ, Burke W, Thomson EJ, editors. Genetics and public health in the 21st century: using genetic information to improve health and prevent disease. New York: Oxford University Press; 2000. pp. 489–504.
Grants and funding
LinkOut - more resources
Full Text Sources